![Todd Brady](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Brady
Directeur/Membre du Conseil chez
CONTINEUM THERAPEUTICS, INC.
Fortune : - $ au 30/06/2026
Profil
Todd R.
Brady currently serves as Director of Finance & Investments at Brace Pharmaceuticals, Inc. since 2014.
Mr. Brady is Director at Vero Biotech, Inc. since 2015.
Mr. Brady is Independent Director at Contineum Therapeutics, Inc. since 2019.
Mr. Brady is Director at Antiva Biosciences, Inc. since 2021.
Mr. Brady is Director at HotSpot Therapeutics, Inc. since 2020.
Former roles include Director at Therabron Therapeutics, Inc., Independent Director at Cocrystal Pharma, Inc. from 2019 to 2020, Independent Director at Avidity Biosciences, Inc. from 2017 to 2021, Director at Tyrogenex, Inc., Director at Viridian Therapeutics, Inc. from 2015 to 2017, Director at Navitor Pharmaceuticals, Inc., and Analyst at Interward Asset Management Ltd. from 2007 to 2008.
Education includes undergraduate studies at the University of Western Ontario and an MBA from The Schulich School of Business conferred in 2007.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Todd Brady
| Sociétés | Poste | Début |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2019 |
Vero Biotech, Inc.
 Vero Biotech, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that focused on the design, development and commercialization of inhaled nitric oxide delivery systems | Directeur/Membre du Conseil | 01/07/2015 |
Brace Pharmaceuticals, Inc.
 Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals invests in companies located in the United States and Brazil. The firm targets companies operating in the fields of bio-pharmaceuticals and biotech. It provides financing for early and late stage capital requirements. | Directeur Financier/CFO | 01/01/2014 |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric therapies | Directeur/Membre du Conseil | 01/05/2020 |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics | Directeur/Membre du Conseil | 01/07/2021 |
Anciens postes connus de Todd Brady
| Sociétés | Poste | Fin |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Directeur/Membre du Conseil | 11/01/2021 |
| COCRYSTAL PHARMA, INC. | Directeur/Membre du Conseil | 10/03/2020 |
| VIRIDIAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/02/2017 |
Interward Asset Management Ltd.
 Interward Asset Management Ltd. Investment ManagersFinance IAML focus on opportunities in North American small and mid-cap companies. The firm uses a rigorous fundamental analysis in achieving a consistent long-term investment performance. In making investment decisions, IAML’s investment process combines top-down sector identification and a strong bottom-up analysis. Their key selling criteria include setting price targets, monitoring performance against expectations, any change in fundamentals, identifying better alternatives and profit taking. | Analyst-Equity | 31/12/2008 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Todd Brady
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Vero Biotech, Inc.
Vero Biotech, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that focused on the design, development and commercialization of inhaled nitric oxide delivery systems | Health Technology |
Therabron Therapeutics, Inc.
 Therabron Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics | Health Technology |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted therapeutics | Health Technology |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Interward Asset Management Ltd.
Interward Asset Management Ltd. Investment ManagersFinance IAML focus on opportunities in North American small and mid-cap companies. The firm uses a rigorous fundamental analysis in achieving a consistent long-term investment performance. In making investment decisions, IAML’s investment process combines top-down sector identification and a strong bottom-up analysis. Their key selling criteria include setting price targets, monitoring performance against expectations, any change in fundamentals, identifying better alternatives and profit taking. | Finance |
Tyrogenex, Inc.
 Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Offers drug discovery and development focused on small molecule kinase inhibitors | Health Technology |
The Schulich School of Business
 The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cocrystal Pharma, Inc.
 Cocrystal Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for use in the treatment of human viral diseases | Health Technology |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals invests in companies located in the United States and Brazil. The firm targets companies operating in the fields of bio-pharmaceuticals and biotech. It provides financing for early and late stage capital requirements. | Finance |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
HotSpot Therapeutics, Inc.
HotSpot Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric therapies | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
